VisionQuest Biomedical
Albuquerque
About VisionQuest Biomedical
VisionQuest Biomedical is a medical device company using artificial intelligence to end preventable blindness. EyeStar, the company's first software application, is used to diagnose diabetic retinopathy in patients' eyes, and Aspire detects malarial retinopathy. The new i-RxTherm is VisionQuest's first technological effort to detect early-stage diabetic disease in areas other than the eyes. VisionQuest's mission is to create and deploy image-based technologies that will improve access to health care for millions of people in the United States and around the world, particularly in the areas of diabetes and eye care.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.5M
- Last round: Grant (Oct 2022)
- Website: visionquest-bio.com
- Phone: 505-508-1994
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/visionquest-biomedical-65300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.